[Differential diagnosis of tuberculosis and other diseases affecting the middle lobe of the lung (lingular lobe)].

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol

Published: August 1981

Based on data resulting from clinical, laboratory, bronchological and radiological correlations investigated in 102 patients with affections involving the median pulmonary lobe (the lingula), the author concluded that no characteristic symptoms can be evidenced, suggesting lesions of the anterior pulmonary areas. The major role in establishing the characteristics of the lesion in this area falls to the radio-bronchological investigation performed specifically for this. According to the radiological aspects the author identified 6 types of broncho-stenotic syndromes involving the median pulmonary lobe, but he stresses that in view of making an etiologic diagnosis the bronchologic investigation, and the cytohistologic study of bioptic material are of major importance. The use of immunologic test is also stressed, in the diagnosis of bronchopulmonary diseases. The author reveals that the diagnosis of "syndrome of the median lobe" cannot replace the exact diagnosis of the disease that should be made in accordance with the nomenclature of the disease and the precise indication of the nosologic form.

Download full-text PDF

Source

Publication Analysis

Top Keywords

involving median
8
median pulmonary
8
pulmonary lobe
8
[differential diagnosis
4
diagnosis tuberculosis
4
tuberculosis diseases
4
diseases middle
4
middle lobe
4
lobe lung
4
lung lingular
4

Similar Publications

Breast cancers of the IntClust-2 type, characterized by amplification of a small portion of chromosome 11, have a median survival of only five years. Several cancer-relevant genes occupy this portion of chromosome 11, and it is thought that overexpression of a combination of driver genes in this region is responsible for the poor outcome of women in this group. In this study we used a gene editing method to knock out, one by one, each of 198 genes that are located within the amplified region of chromosome 11 and determined how much each of these genes contributed to the survival of breast cancer cells.

View Article and Find Full Text PDF

Novel Meningoencephalomyelitis Associated With Vimentin IgG Autoantibodies.

JAMA Neurol

January 2025

Department of Neurology, Xuanwu Hospital Capital Medical University, National Center for Neurological Disorders, Beijing, China.

Importance: Autoantibodies targeting astrocytes, such as those against glial fibrillary acidic protein (GFAP) or aquaporin protein 4, are crucial diagnostic markers for autoimmune astrocytopathy among central nervous system (CNS) autoimmune disorders. However, diagnosis remains challenging for patients lacking specific autoantibodies.

Objective: To characterize a syndrome of unknown meningoencephalomyelitis associated with an astrocytic autoantibody.

View Article and Find Full Text PDF

Aneurysmal rupture in microscopic polyangiitis: a case-based review.

Clin Rheumatol

January 2025

Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.

Microscopic polyangiitis (MPA) affects small and medium vessel, which sometimes leads to arterial aneurysms. In English database, only 15 reports refer to ruptured aneurysms in MPA. We experienced a fatal case with MPA who developed multiple visceral aneurysms, resulting in rupture of the hepatic aneurysm.

View Article and Find Full Text PDF

Chordoma is a rare malignant tumor with a higher incidence in males than in females. There is an increasing number of clinical studies related to tyrosine kinase inhibitors (TKIs), yet the efficacy and safety of different drugs vary. In this single-arm meta-analysis evaluating the efficacy and safety of TKIs for chordoma treatment, 12 studies involving 365 patients were analyzed.

View Article and Find Full Text PDF

Purpose: This phase II study is designed to evaluate the combination therapy involving suvemcitug and envafolimab with FOLFIRI in microsatellite-stable or mismatch repair-proficient (MSS/pMMR) colorectal cancer (CRC) in the second-line treatment setting.

Methods: This study is a non-randomized, open-label prospective study comprising multiple cohorts (NCT05148195). Here, we only report the data from the CRC cohort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!